iBankCoin
18 years in Wall Street, left after finding out it was all horseshit. Founder/ Master and Commander: iBankCoin, finance news and commentary from the future.
Joined Nov 10, 2007
23,447 Blog Posts

Omega Advisors Receives Wells Notice from SEC

Legendary money changer, Leon Cooper, received a Wells Notice from the SEC today, for trading taking place in 2010.

Omega Advisors declined to comment on the matter.

Omega has approximately $5 billion under management. Their largest positions, based on recent filings, were GOOGL, AGN, AER and CIM–spread out, piecemeal style, avoiding the risk of overly concentrated gambles.

Comments »

Markets Tread Water; Biotechs Rage Higher

Just about 50% of stocks traded higher today, absorbing malevolent news from two different Fed heads –whose intentions were to hurt investors with invidious designs. The standouts were abundant in biotech, a sector that has appreciably underperformed the markets for 2016. While all sectors are currently in the black for 2016, biotechs remain lower to the tune of -12%.

Here were some standouts in the sector.

Biotech

Energy related stocks took a breather, but firmed up a bit late in the day. Without question, short sellers are on the run from crazy men firing trebuchets. Bonds traded lower, as yields spiked. A calm breezy mood persists on Wall, paving a clear and indelible path towards higher prices.

Comments »

Today’s Short Squeezes, Courtesy of Exodus

A slow sleepy market is the perfect occasion to lay waste to short sellers. One of the more notable breakouts is SQ, Jack Dorsey’s other publicly traded company.

squeeze

On the proprietary momentum screen there are a litany of biotech stocks found, such as  ARIA, FGEN, HALO, INSY and SRPT.

Comments »

Tim Cook: We Will Not Shrink (no homo) From This Responsibility

Future former CEO of Apple, Tim Cook, said in a speech given today that the company would not shrink from the responsibility of protecting the data embedded in their ridiculous iPhones. He doesn’t give a shit about the government’s requests and if Hitler himself had war plans on his iPhone, circa 1940s, Apple would not be obliged to hack into it for the benefit of the allied powers.

Speaking of shrinking, Apple unveiled two smaller items that zero Americans will buy: a smaller iPhone and Ipad pro. Also, they lowered the price of the iWatch, since no one buys them. Additionally, they unveiled new bands for that caricature of a time piece.

Good day.

Comments »

Fed’s Lockhart, Williams: Emergency April Rate Hike is Possible

Markets are evidently rallying on the news of an emergency rate hike being supplanted upon the market in April. Just a few days ago, the market was slathering itself in the refuse of zero rate hikes through 2016. Then the Fed meeting revealed ‘maybe 1 or 2’, as early as June. Well, today, two Fed officials, Lockhardon and Williams, said in separate, but deliberate, speeches that a hike was possible as early as April.

If done, this would be a non-conference meeting, which could be construed as something being done posthaste and without regard for market sensitivities.

Seeing the market up, one could only imagine it enjoys this flair coming out from the Federal Reserve and looks forward to future emergency tightenings–because inflation and full employment are such pressing issues of our time.

FML.

Comments »

Valeant Pharmaceuticals Welcomes a Mr. William A. Ackman to its Board; Stock Soars

Pearson is out; Ackman is in. The former CFO, Howard Schiller, was asked to resign from the board, but refused to do so.

What?!

Ackman isn’t sending a surrogate in to represent Pershing’s interests. He’s doing it himself, telling of the seriousness surrounding this move. For Schiller to remain on board, obstinently, one could only imagine there is some serious turmoil behind the scenes.

After 8 years, Pearson is out, hung by his own petard.

Ackman’s statement regarding the appointment:

“I am looking forward to working with the board to identify new leadership for Valeant. The company’s large scale and dominant franchises in eye care, dermatology, GI, and other therapeutic areas coupled with its extraordinarily low valuation present a spectacular opportunity for a world-class health care executive. On behalf of all shareholders, we are extremely appreciative of Valeant employees’ hard work and commitment during this challenging time for the company.”

Ack-attack should’ve went hostile from the beginning, removing the troll, Pearson, from the company immediately. Instead, he had to wait until Nagasaki befell the share price and his fund to act. Hopefully, his actions aren’t too late. I don’t know what I’d do if Montauk Bill wasn’t around Wall Street kicking up dirt, making a big old soap opera of the place.

Alarmingly, it appears the entire biotech index is now tethered to the shares of VRX.
image

image

Comments »

JP Morgan: Reduce Market Exposure; Don’t Chase Crude

JP Morgan’s global head of equity strategy, Steven Rees, isn’t a fan of this rally. As a matter of fact, it’s already higher than his year end target. As such, ergo, he recommends that you remove the beer bottle from your mouths and collectively sell your stocks in order to reallocate into a dividend stock buying strategy. Granted, this plot of his seems a bit convoluted and a tad hypocritical. After all, if stocks are truly overpriced, why not suggest cash?

Nevertheless, he wants everyone to know, aside from his wanton hatred for equities, he is NOT a fan of oil, especially after bargaining its nefarious way up to $40.

Oh, but he thinks earnings should get much better in the second half of the year, so you might need to ignore everything he just said.

Comments »

Fed’s Lacker: Inflation is Coming

Here we go again. Expect a litany of jargon from these Fed heads, trying to prime us to be painted red by a barrage of Federal Reserve hikes. Just the other day, Bullard suggested that low rates might be causing low inflation. Ergo, we should hike them in order to raise inflation.

The fuck?

Has it occurred to any of these brainiacs that the cause of deflation is DEBILITATING DEBT, which causes fiscal spending to be constrained and unproductive? Just a theory of mine.

Lacker in Paris today:

“The recent data on inflation – because they have come in firmer than expected – suggests that upside risks to inflation have increased maybe not significantly, but I think noticeably and materially,” Lacker said at a central banking conference at the Bank of France in Paris.

“We need to take that into consideration,” he said, adding that he expected core inflation firmer this year than last year and close to 2 percent in 2017.

The U.S. central bank said in its Wednesday policy statement that financial market-based measures of expected inflation were low.

“Although recent declines in inflation compensation do give me some pause, I think the evidence indicates that inflation expectations … remain well-anchored,” Lacker said. He cited studies that suggest public expectations of inflation guide actual price changes.

Let’s see if the market really likes the idea of higher rates, or if it was just kidding when it acted like it did for the past 5 weeks.

Comments »

Goldman: The Fed Must Raise Aggressively to Avoid ‘Significant Overheating’

Sometimes I think these economists ingest psychedelic mushrooms before penning this cock-eyed stories. Hang on, let me take this shit serious for a second and stop laughing at it. Okay, I’m ready.

In order to avoid a significant overheating in the U.S. economy, the Fed must cease being the central bank for the world and instead return to their station at central bank for America. Moreover, it’s incumbent upon them to stave off debilitating inflation, affected by a rapidly increasing employment index, by hiking rates FOUR times this year.

“One interpretation of the recent moves by the European Central Bank and the Federal Reserve is that they represent coordinated attempt to ease global financial conditions while avoiding upward pressure on the U.S. dollar, especially against the Chinese renminbi,” write Chief Economist Jan Hatzius and Economist Sven Jari Stehn of Goldman Sachs Group Inc, giving a nod to the so-called “Plaza Accord 2.0” theory.

“To guard against significant overheating, we think that the FOMC would want output and employment growth to slow as we enter 2017,” the economists write. “But this seems inconsistent with the current setting of financial conditions.”

Put another way, if the blowout in spreads and strength of the dollar still hasn’t been enough to stop the U.S. unemployment rate from declining steadily—which implies that growth has been above-trend—then that alone is enough evidence to suspect much more tightening is required to rein in activity to a level at which the economy won’t be running too hot.

Goldman estimates that the Fed will need to carry out four rate hikes this year in order to strike this balancing act and avoid a more brisk removal of monetary accommodation later that could tip the economy into recession.

In other words, the strength of the domestic economy will soon force the Fed to return to being the central bank for the U.S., rather than the world.
“If we are right, the Fed’s willingness to keep policy easier for longer in the name of global policy coordination is likely to be short-lived and the funds rate will rise significantly further than currently discounted in the bond market,” conclude Hatzius and Stehn.

Both Hatzius and Stehn are morons of the first magnitude. These economists at Goldman are delusional, playful thinkers, men clad in velcro hoodies playing with their feces inside of rubber rooms.

Comments »

Will the Valeant Pain Ever End?

At this point, the Valeant agony is minimized only by the reduced size in an already tattered position. Firms like Valueact and Pershing Square have endured heinous, unforgivable, losses at the hands of a M. Pearson. The bedraggled CEO of VRX is a fat, disgusting, troll of a man, who circumvents the world in search for orphan drugs, for the explicit purposes of raising their prices.

This business model, once revered by the Wall Street elite, has proven to be woeful.

Here we are, pre-market, and the stock is getting hammered on heavy volume, down 4.5% to $25.77.

image

As I am writing this, shares are halted with news pending. The way I see it, Pearson has to go, immediately. Since the business model is broken and their debt load is becoming an issue for the never-ending spiraling equity, they need to do a capital raise. At this point, the only thing that can turn the shares around is a takeover of the entire company. Even if that occurred, the geniuses who went long above $200 will never recover their original investment.

The tides have turned, permanently, for VRX and their ilk, which include ENPD and MNK.

Comments »